- 041MarketSource · Medical Design & Outsourcing
Tecomet and Orchid complete merger, form global platform
Tecomet and Orchid Orthopedic Solutions completed their merger, creating a scaled global manufacturing platform. The combination is positioned to strengthen technical capabilities, expand global footprint, and improve supply resilience for OEM customers across medical device manufacturing.
- 042MarketSource · MedCity News
Shyld AI Snags $13M for Device that Disinfects Hospital Rooms Autonomously
Shyld AI raised $13.4 million to expand its AI-powered UV disinfection platform that autonomously sanitizes hospital rooms. The technology targets reduction of hospital-acquired infections and reduces dependence on manual cleaning labor.
- 043MarketSource · Medical Device Network
UroMems eyes regulatory filings for SUI treatment after $60m fundraise
UroMems raised $60 million in funding to advance its UroActive system toward regulatory submission for stress urinary incontinence treatment. The company plans to use the capital to complete a pivotal trial supporting FDA and CE mark applications in the US and Europe.
- 044MarketSource · Medical Device Network
Rivermark pockets $20m in Series D for late-stage prostate device trial
Rivermark Medical raised $20 million in Series D funding to advance its pivotal trial for FloStent, a device designed to treat benign prostatic hyperplasia. The capital will support late-stage clinical development of the minimally invasive urology device.
- 045MarketSource · Medical Design & Outsourcing
Velosity launches innovation lab in Minnesota
Velosity opened a 5,000 sq ft innovation lab at its Brooklyn Park, Minnesota machining center of excellence, a multi-million-dollar facility that began development in September. The lab supports Velosity's contract manufacturing and product development capabilities for medical device makers.
- 046MarketSource · Medical Design & Outsourcing
Nissha breaks ground on manufacturing expansion in Wisconsin
Nissha Medical Technologies, the medical devices unit of Japan's Nissha Co., broke ground on a new 50,000-square-foot manufacturing facility in New Richmond, Wisconsin. The expansion targets its micro molding operations to increase capacity for miniaturized, precision-molded components in response to growing demand.
- 047MarketSource · Medical Device Network
Latest foreign investment in UK highlights underserved potential of primary care technology
Doctolib, a European digital health supplier, has acquired Medicus, a UK-based NHS GP technology provider, as part of a broader expansion strategy in the UK market. The deal underscores growing investor interest in primary care technology infrastructure.
- 048MarketSource · Mobi Health News
Omada Health reports 42% revenue growth in Q1 2026 earnings
Omada Health, a San Francisco-based virtual care platform specializing in chronic disease management for diabetes, cardiometabolic conditions, hypertension, and musculoskeletal disorders, reported 42% year-over-year revenue growth in Q1 2026, one year after its NASDAQ debut. The company delivers behavior-change coaching and health tracking capabilities to its user base.
- 049MarketSource · Mobi Health News
Latest Middle East partnerships expanding Korean health tech and more briefs
South Korean medtech firms ROKIT Healthcare and Seers have signed partnerships with Middle Eastern healthcare companies to expand their AI-enabled monitoring and diagnostic technologies. ROKIT Healthcare licensed its chronic kidney disease prediction AI algorithm to Saudi Arabia-based LifeHope for integration into its Longevity platform, while Seers expanded its inpatient monitoring capabilities through a separate regional partnership.
- 050MarketSource · Medical Device Network
BD uplifts FY26 revenue outlook based on steady portfolio performance
Becton Dickinson raised its FY26 revenue guidance, reversing a prior downward revision from Q1 that stemmed from the divestiture of its diagnostics business to Waters Corporation. The uplift reflects improved performance across BD's remaining portfolio.
- 051MarketSource · Medical Device Network
Roche to acquire PathAI in $1.05bn deal
Roche signed a definitive merger agreement to acquire PathAI for up to $1.05 billion. PathAI develops AI-powered digital pathology software for analyzing histopathology images. The acquisition expands Roche's diagnostics and AI capabilities in pathology and precision medicine.
- 052MarketSource · MedCity News
Startup Enabling Aging at Home Raises $6M, Gains New MA and Medicaid Partnerships
Rosarium Health, a startup focused on aging-in-place solutions, closed a $6 million seed round led by Kalos Ventures with participation from ResilienceVC, Rock Health Capital, and others. The company simultaneously announced new partnerships with Massachusetts and Medicaid programs to expand access to its homecare platform.
- 053MarketSource · Medical Device Network
BD and Wellstar partner to improve hospital medication delivery systems
BD and Wellstar Health System have announced a partnership to enhance medication delivery safety and efficiency across Wellstar's hospital and care facility network. The collaboration aims to optimize medication management processes and reduce errors in drug administration.
- 054MarketSource · Mobi Health News
HealthVerity to acquire data platform Symphony Health
HealthVerity announced plans to acquire Symphony Health, a commercial healthcare data and analytics platform. The combined entity will integrate clinical data with commercial insights to serve life sciences companies, payers, and government entities seeking real-world data, patient research recruitment, and cross-dataset record linkage capabilities.
- 055MarketSource · Mobi Health News
Exclusive: XCaliber Health scores $6.5M for workflow platform
XCaliber Health raised $6.5 million in seed funding for its agentic AI platform designed to reduce administrative burden in healthcare settings. The funding will support nationwide expansion of the workflow automation platform.
- 056MarketSource · Medical Device Network
Olympus to distribute EndoRobotics’ technologies worldwide
Olympus has secured an exclusive global distribution agreement for EndoRobotics' robot-assisted technologies, integrating them into its EndoTherapy product portfolio. The deal expands Olympus's surgical robotics offerings to healthcare providers worldwide.
- 057MarketSource · Medical Design & Outsourcing
Confluent Medical Technologies opens nitinol wire manufacturing facility in India
Confluent Medical Technologies opened a 26,000-square-foot nitinol wire manufacturing facility in Hyderabad, India, doubling its production capacity for the material. The Nitinol Wire Center of Excellence represents the contract manufacturer's investment in expanding supply of nitinol, a shape-memory alloy used in minimally invasive devices and guidewires.
- 058MarketSource · Mobi Health News
Enzo Health raises $20M to expand AI home health platform
Enzo Health, a home health and post-acute care platform using AI, closed a $20 million Series A funding round led by N47, with participation from Gradient, Tandem Ventures, and Rigby Watts. The capital will support expansion of the company's AI-driven home health offerings. Total funding to date is $26 million.
- 059MarketSource · Medical Device Network
Stryker maintains FY26 outlook despite cyberattack-impacted Q1
Stryker experienced a cyberattack in March 2026 that disrupted operations and impacted first-quarter performance. Despite the incident, the company maintained its full-year 2026 financial outlook, indicating management confidence in recovery and continued execution of business plans.
- 060MarketSource · Medical Device Network
Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook
Dexcom reported 15% year-over-year revenue growth in Q1 but chose not to raise its full-year FY26 guidance, citing geopolitical uncertainties. The continuous glucose monitoring vendor maintained its prior outlook despite the stronger-than-expected quarterly performance.
- 061MarketSource · Medical Device Network
MintNeuro and Motif Neurotech collaborate for mental health therapies
MintNeuro and Motif Neurotech have entered a partnership to develop miniature brain-computer interface (BCI) therapy for mental health applications. The collaboration aims to advance BCI technology for therapeutic use, combining the companies' expertise in neural interfaces and neurotech innovation.
- 062MarketSource · Medical Device Network
GE HealthCare’s stock plunges 13% as supply chain costs bite
GE HealthCare lowered its 2026 growth forecast, citing rising freight costs and material expenses. The revision, a 3.3 percentage-point reduction at the top end of guidance, prompted a 13% stock decline. The move reflects broader supply chain pressures affecting the medical device manufacturer's outlook.
- 063MarketSource · Medical Device Network
Axoft raises $55m to advance BCI made of Fleuron
Axoft has raised $55 million in funding to advance clinical trials and US regulatory activities for its implantable brain-computer interface (BCI) device. The capital will support ongoing trial programmes and FDA pathway development for the technology.
- 064MarketSource · Mobi Health News
Nervonik raises $52.5M to enhance peripheral nerve stimulation system
Nervonik, a peripheral nerve stimulation device developer, closed a $52.5 million Series B funding round led by Amzak Health. The oversubscribed round included participation from Elevage Medical Technologies, U.S. Venture Partners, Lumira Ventures, Foothill Ventures, and Shangbay Capital. The capital will support enhancement of the company's nerve stimulation platform.
- 065MarketSource · Mobi Health News
Aidoc secures $150M to scale AI imaging tools
Aidoc, an AI imaging software company, closed a $150 million Series E funding round led by Goldman Sachs Growth Equity, with participation from General Catalyst, SoftBank Investment Advisors, and NVIDIA Ventures. The round brings total capital raised to over $500 million. Aidoc develops AI-enabled tools for diagnostic imaging analysis.
- 066MarketSource · Medical Device Network
CareDx sharpens precision medicine focus with $260m Naveris acquisition
CareDx announced a $260 million acquisition of Naveris, a precision medicine company, as part of a strategic shift following the recent divestment of its lab products business. The move reflects CareDx's decision to refocus on precision medicine after its lab segment reported flat Q1 revenue.
- 067MarketSource · MedCity News
Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy
Telehealth clinic Hone Health partnered with imaging vendor BodySpec to offer DEXA body composition scans to GLP-1 patients. The collaboration aims to help providers differentiate fat loss from muscle loss during treatment, enabling more detailed assessment of drug efficacy beyond weight metrics alone. The partnership represents a vendor strategy move to integrate diagnostic imaging into remote weight-management workflows.
- 068MarketSource · Mobi Health News
Courier Health scores $50M to scale CRM technology
Courier Health, a health tech platform serving life sciences manufacturers, closed a $50 million Series B funding round led by Oak HC/FT, with participation from Norwest and Work-Bench. The New York-based company provides CRM technology to help manufacturers manage customer relationships and sales operations.
- 069MarketSource · MedCity News
Top Silicon Valley VCs Are Backing a New Health Tech Residency Program
The AI Health Fund launched Treehub, a residency program for early-stage healthcare AI startups, backed by prominent venture investors including Tim Draper and Anne Wojcicki. The program targets companies at pre-formation stages, signaling continued capital flow into the health tech vendor ecosystem.
- 070MarketSource · Medical Device Network
Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook
Boston Scientific reported 11.2% year-over-year growth in Q1 2026 but reduced its full-year 2026 revenue guidance, trimming the top-end growth outlook by 2 percentage points. The adjustment signals caution amid what the company characterized as steady near-term performance across its device portfolio.
- 071MarketSource · Medical Device Network
AcuityMD raises $80m for AI augmentation to medtech sales platform
AcuityMD secured $80 million in funding to expand its AI-powered sales platform serving medical device companies. The platform is designed to streamline commercial execution and sales operations for medtech vendors. The fresh capital will support integration of advanced AI capabilities into the existing system.
- 072MarketSource · Medical Design & Outsourcing
CPC Biotech debuts unified bioprocess fluid portfolio
CPC Biotech has launched as a unified brand combining CPC's biopharma connectors with PSG Biotech's pumps, flow meters, and sensors into an integrated bioprocess fluid management portfolio. The company will debut publicly at INTERPHEX 2026 in April at the Javits Center in New York City. The consolidation brings together critical fluid handling components and expertise for biopharmaceutical manufacturing.
- 073MarketSource · Medical Design & Outsourcing
Henry Schein discloses exec pay for longtime CEO Stan Bergman’s final year
Henry Schein disclosed executive compensation for 2025, reporting pay increases for three of five top executives in what marks longtime CEO Stan Bergman's final year leading the Melville, New York-based medical products distributor. The company also raised median employee compensation year-over-year. Bergman has led Henry Schein, ranked among the world's largest medical device suppliers, for an extended tenure.
- 074MarketSource · MedCity News
Eli Lilly Makes Another In Vivo Genetic Medicines Move With $3.2B Kelonia Acquisition
Eli Lilly acquired Kelonia Therapeutics for $3.2 billion to add an in vivo cell therapy program targeting multiple myeloma. The deal marks Lilly's third genetic medicines acquisition in as many years, following purchases of Verve and Orna Therapeutics, as the pharmaceutical giant diversifies its approach to in vivo genetic therapy across multiple platforms and disease targets.
- 075MarketSource · Medical Design & Outsourcing
Abbott’s device leader pay climbs again with double-digit sales growth
Abbott's EVP and Medical Devices Group President Lisa Earnhardt received a compensation package increase exceeding 20% in 2025, reflecting double-digit sales growth in the division. Abbott ranked eighth globally among medical device companies by revenue in the latest Medtech Big 100 rankings. The pay rise underscores strong financial performance in the device segment amid broader market momentum.
- 076MarketSource · Medical Design & Outsourcing
Switchback Medical is expanding into Costa Rica
Switchback Medical, a medical device contract development and manufacturing organization, has signed a lease for an 18,000-square-foot facility in Costa Rica's Coyol Free Trade Zone. The expansion marks the company's first international manufacturing footprint outside its Brooklyn Park, Minnesota headquarters, signaling a strategic shift in production capacity and supply-chain positioning for the CDMO sector.
- 077MarketSource · Medical Design & Outsourcing
CDMO Arterex upgrades manufacturing facility near Boston
Arterex, a contract device manufacturer, is expanding its Mansfield, Massachusetts facility by 15,000 square feet and installing a new steam sterilizer to boost operational capacity by nearly 50%. The upgrade aims to improve inventory control and logistics efficiency for its contract manufacturing customers.
- 078MarketSource · Medical Design & Outsourcing
Medtech CDMO Integer discloses executive pay after new CEO steps in
Integer Holdings Corp., a contract manufacturer and CDMO for medical devices, disclosed executive compensation packages following a new CEO appointment in an SEC filing. The company also reported a significant increase in median employee pay. Integer ranks among the top 60 medical device companies globally.
- 079MarketSource · Fierce Healthcare
Whoop raises $575M series G, Abbott comes on board amid hiring spree
Whoop, a fitness wearable maker, raised $575 million in Series G funding with Abbott as a new investor. The round comes as Whoop expands hiring and positions itself for growth in the consumer health monitoring space. Abbott's participation signals potential distribution or integration opportunities between the companies.
- 080MarketSource · Fierce Healthcare
Medline makes Nasdaq debut, raising $6.26B in year's largest IPO
Medline Industries completed its Nasdaq initial public offering, raising $6.26 billion in the largest IPO of 2024. The medical device and supply distributor, previously held by private equity, transitions to public ownership. The offering marks a significant milestone for one of the U.S.'s largest medical equipment and consumables vendors and signals investor appetite for established medical-supply businesses.